Literature DB >> 21082280

Hepatocyte growth factor and keratinocyte growth factor enhance IL-1-induced IL-8 secretion through different mechanisms in Caco-2 epithelial cells.

Benjamin L Unger1, Dennis W McGee.   

Abstract

A variety of cytokines have been detected in inflamed intestinal mucosal tissues, including the pro-inflammatory cytokine, interleukin-1 (IL-1), along with growth factors involved in wound healing processes such as proliferation and cell migration. However, little is known about how IL-1 and growth factors interact with intestinal epithelial cells to regulate the production of inflammatory cytokines such as interleukin-8 (IL-8). Previously, we have shown that hepatocyte growth factor (HGF) could significantly enhance IL-1-stimulated IL-8 secretion by the Caco-2 colonic epithelial cell line, yet HGF, by itself, did not stimulate IL-8 secretion. In this report, a second growth factor, keratinocyte growth factor (KGF), was also found to significantly enhance IL-1-induced IL-8 secretion by Caco-2 cells, yet KGF, by itself, also had no effect. Simultaneous addition of both IL-1 and KGF was also required for the enhancing effect. Treatment of the Caco-2 cells with wortmannin or triciribine suppressed the enhancing effect of HGF, suggesting that the effect was mediated by signaling through phosphatidylinositol-3-kinase (PI3K) and the kinase AKT. The enhancing effect of KGF was not affected by wortmannin, but was suppressed by triciribine, suggesting that the effect of KGF was through a PI3K-independent activation of AKT. These results suggest that the growth factors HGF and KGF may play a role in enhancing IL-1-stimulated production of IL-8 by epithelial cells during mucosal inflammations. However, the mechanism by which the growth factors enhance the IL-1 response may be through different initial signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21082280      PMCID: PMC3042507          DOI: 10.1007/s11626-010-9365-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  40 in total

1.  HGF- and KGF-induced activation of PI-3K/p70 s6 kinase pathway in corneal epithelial cells: its relevance in wound healing.

Authors:  G Chandrasekher; A H Kakazu; H E Bazan
Journal:  Exp Eye Res       Date:  2001-08       Impact factor: 3.467

2.  Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.

Authors:  G Dong; Z Chen; Z Y Li; N T Yeh; C C Bancroft; C Van Waes
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

3.  Efficacy of repifermin (keratinocyte growth factor-2) against abnormalities in gastrointestinal mucosal transport in a murine model of colitis.

Authors:  B Greenwood-Van Meerveld; K Venkova; K Connolly
Journal:  J Pharm Pharmacol       Date:  2003-01       Impact factor: 3.765

4.  Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease.

Authors:  P W Finch; A L Cheng
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

5.  Keratinocyte growth factor activates p38 MAPK to induce stress fibre formation in human prostate DU145 cells.

Authors:  P B Mehta; C N Robson; D E Neal; H Y Leung
Journal:  Oncogene       Date:  2001-08-30       Impact factor: 9.867

Review 6.  Ten years of protein kinase B signalling: a hard Akt to follow.

Authors:  D P Brazil; B A Hemmings
Journal:  Trends Biochem Sci       Date:  2001-11       Impact factor: 13.807

7.  Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

Authors:  Lin Yang; Han C Dan; Mei Sun; Qiyuan Liu; Xia-meng Sun; Richard I Feldman; Andrew D Hamilton; Mark Polokoff; Santo V Nicosia; Meenhard Herlyn; Said M Sebti; Jin Q Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.

Authors:  L Grier Arthur; Marshall Z Schwartz; Keith A Kuenzler; Ruth Birbe
Journal:  J Pediatr Surg       Date:  2004-02       Impact factor: 2.545

9.  Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells.

Authors:  N Rahimi; E Tremblay; B Elliott
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

10.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.

Authors:  M Ligumsky; P L Simon; F Karmeli; D Rachmilewitz
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

View more
  4 in total

1.  Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).

Authors:  Raymond S Douglas; Tünde Mester; Anna Ginter; Denise S Kim
Journal:  Trans Am Ophthalmol Soc       Date:  2014

2.  Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.

Authors:  Le Tao; Jianxin Qiu; Ming Jiang; Wenbin Song; Shuyuan Yeh; Hong Yu; Lijuan Zang; Shujie Xia; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261

Review 3.  Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge.

Authors:  Wasia Rizwani; Amanda E Allen; Jose G Trevino
Journal:  Cancers (Basel)       Date:  2015-09-03       Impact factor: 6.639

4.  Initiation of human astrovirus type 1 infection was blocked by inhibitors of phosphoinositide 3-kinase.

Authors:  Shoichiro Tange; Yan Zhou; Yuko Nagakui-Noguchi; Takeshi Imai; Akira Nakanishi
Journal:  Virol J       Date:  2013-05-16       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.